Skip to content

Hims & Hers Health HIMS Other Financing

Other Financing at other companies

Kenvue logo
KenvueKVUE
-$17M-163%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$50K-88.9%
Henry Schein logo
Henry ScheinHSIC
$0-100%
Humana logo
HumanaHUM
-$18M-50.0%
Amgen logo
AmgenAMGN
-$104M-285%
Chewy logo
ChewyCHWY
-$1.5M+48.3%

Other financials

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Cash & equivalents$222.3M-19.2%
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation

See full
Market cap$8.21B-27.9%
Enterprise value$8.15B-26.5%
P/S3.5×-2.9×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hims & Hers Health's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hims & Hers Health's other financing?
Hims & Hers Health (HIMS) reported other financing of $43.68M in Q1 2026.
What does other financing mean?
Miscellaneous cash inflows or outflows related to the company's financing structure.
How do you interpret other financing?
Large fluctuations may indicate non-recurring financing events or accounting adjustments that require further investigation.
How does other financing compare across companies?
Varies significantly by company; often contains noise that is not core to the primary financing strategy.